logo-loader
ASX:MDC

Medlab Clinical Ltd

 Receive alerts
Market:
ASX
Market Cap:
$96.91 m
Price
0.45 AUD
Change
0.00%
52 weeks high
0.56
52 weeks low
0.34

In brief

Medlab Clinical Ltd (ASX:MDC) is listed on the Australian Securities Exchange.

In brief Deep dive Research Latest news Insight Interviews

Deep dive We explore the investor case for growth companies

Medlab Clinical takes EMA and FDA approval track as cannabis research continues
Sydney Harbour Bridge

Snapshot

A phase I study in Australia is evaluating a cannabis spray therapeutic in cancer patients.

Open Deep dive

Latest news

Medlab Clinical converts HoA into commercial agreement for US expansion

1 week ago

Medlab Clinical begins NanoCBD manufacturing after first export order for...

2 weeks, 1 day ago

Medlab Clinical obtains positive data proving efficacy of NanaBidial...

on 16/8/19

Medlab Clinical continues US expansion with HoA

on 5/8/19

Medlab Clinical achieves over $3 million revenue for June quarter, shares rise

on 4/7/19

Medlab Clinical receives human ethics approval for cannabis-based pain...

on 18/6/19

Medlab Clinical signs second international distribution deal for NanaBis

on 28/5/19

Medlab Clinical collaborates with Chronic Pain Australia

on 16/4/19

Interviews

1557286341_MDC-thumb.jpg Health Medlab Clinical forges ahead in new vitamin trials for chronic illnesses
on 8/5/19
1552359852_MDC-MAR.jpg Health Medlab Clinical chief updates on progress with NanaBis and NRG Biotic
on 12/3/19
1549513375_MDC-FEB.jpg Health Medlab Clinical accelerating VMS business in Australia, and NanaBis globally
on 7/2/19
1544676046_MDC-thumb.jpg Health MedLab Clinical plans European product expansion with wholly-owned subsidiary
on 13/12/18
View all